Muscle-Invasive Bladder Cancer: Difference between revisions
Urology4all (talk | contribs) |
Urology4all (talk | contribs) |
||
| Line 156: | Line 156: | ||
*'''<span style="color:#ff0000">2020 AUA Muscle-Invasive Bladder Cancer Guidelines</span>''' | *'''<span style="color:#ff0000">2020 AUA Muscle-Invasive Bladder Cancer Guidelines</span>''' | ||
*#'''<span style="color:#ff0000">eGFR < 60ml/min | *#'''<span style="color:#ff0000">eGFR < 60ml/min</span>''' | ||
*# '''<span style="color:#ff0000">Heart failure (NYHA Class > 2)</span>''' | *# '''<span style="color:#ff0000">Heart failure (NYHA Class > 2)</span>''' | ||
*# '''<span style="color:#ff0000">≥Grade 2 hearing loss</span>''' (grading based on Common Terminology Criteria for Adverse Events version 4.0) | *# '''<span style="color:#ff0000">≥Grade 2 hearing loss</span>''' (grading based on Common Terminology Criteria for Adverse Events version 4.0) | ||